Aknoten
Brand names,
Aknoten
Analogs
Aknoten
Brand Names Mixture
Aknoten
Chemical_Formula
C20H28O2
Aknoten
RX_link
http://www.rxlist.com/cgi/generic/tretinoin.htm
Aknoten
fda sheet
Aknoten
msds (material safety sheet)
Aknoten
Synthesis Reference
Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)
Aknoten
Molecular Weight
300.435 g/mol
Aknoten
Melting Point
181 oC
Aknoten
H2O Solubility
<0.1 g/100 mL
Aknoten
State
Solid
Aknoten
LogP
5.067
Aknoten
Dosage Forms
Capsule; Cream; Gel; Liquid
Aknoten
Indication
For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.
Aknoten
Pharmacology
Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).
Aknoten
Absorption
1-31% (topical);
Aknoten
side effects and Toxicity
No information avaliable
Aknoten
Patient Information
No information avaliable
Aknoten
Organisms Affected
Humans and other mammals